| Literature DB >> 32152230 |
Mingle Dou1, Ying Yao1, Lu Ma1, Xiaoyu Wang1, Xin'e Shi1, Gongshe Yang1, Xiao Li2.
Abstract
Mammalian skeletal muscles comprise different types of muscle fibers, and this muscle fiber heterogeneity is generally characterized by the expression of myosin heavy chain (MyHC) isoforms. A switch in MyHC expression leads to muscle fiber-type transition under various physiological and pathological conditions, but the underlying regulator coordinating the switch of MyHC expression remains largely unknown. Experiments reported in this study revealed the presence of a skeletal muscle-specific antisense transcript generated from the intergenic region between porcine MyHC IIa and IIx and is referred to here as MyHC IIA/X-AS. We found that MyHC IIA/X-AS is identified as a long noncoding RNA (lncRNA) that is strictly expressed in skeletal muscles and is predominantly distributed in the cytoplasm. Genetic analysis disclosed that MyHC IIA/X-AS stimulates cell cycle exit of skeletal satellite cells and their fusion into myotubes. Moreover, we observed that MyHC IIA/X-AS is more enriched in fast-twitch muscle and represses slow-type gene expression and thereby maintains the fast phenotype. Furthermore, we found that MyHC IIA/X-AS acts as a competing endogenous RNA that sponges microRNA-130b (miR-130b) and thereby maintains MyHC IIx expression and the fast fiber type. We also noted that miR-130b was proved to down-regulate MyHC IIx by directly targeting its 3'-UTR. Together, the results of our study uncovered a novel pathway, which revealed that lncRNA derived from the skeletal MyHC cluster could modulate local MyHC expression in trans, highlighting the role of lncRNAs in muscle fiber-type switching.Entities:
Keywords: MyHC; lncRNA; long noncoding RNA (long ncRNA, lncRNA); microRNA (miRNA); muscle fiber type; muscle physiology; myogenesis; skeletal muscle
Mesh:
Substances:
Year: 2020 PMID: 32152230 PMCID: PMC7152763 DOI: 10.1074/jbc.RA119.010498
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157